150 related articles for article (PubMed ID: 26645696)
1. Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
Liu YM; Li Y; Wei WB; Xu X; Jonas JB
PLoS One; 2015; 10(12):e0144562. PubMed ID: 26645696
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
3. Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan.
Zewar A; Nawaiseh I; Jaradat I; Khzouz J; Alrawashdeh K; Abdeen G; Mehyar M; Khurma S; Yousef YA
Turk Patoloji Derg; 2016; 32(3):186-92. PubMed ID: 27562393
[TBL] [Abstract][Full Text] [Related]
4. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
6. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
Quivey JM; Augsburger J; Snelling L; Brady LW
Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognostic factors of 1 166 patients with uveal melanoma].
Luo JT; Yang YH; Liu YM; Li Y; Wei WB
Zhonghua Yan Ke Za Zhi; 2022 Jul; 58(7):529-534. PubMed ID: 35796126
[No Abstract] [Full Text] [Related]
8. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
9. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983
[TBL] [Abstract][Full Text] [Related]
10. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
11. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
[TBL] [Abstract][Full Text] [Related]
12. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
[TBL] [Abstract][Full Text] [Related]
13. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
14. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
15. Uveal melanoma in young patients.
Pogrzebielski A; Orłowska-Heitzman J; Romanowska-Dixon B
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1646-9. PubMed ID: 16636835
[TBL] [Abstract][Full Text] [Related]
16. [Diffuse malignant melanoma of the uvea. A clinico-histopathologic study of 39 patients].
Braun UC; Rummelt VC; Naumann GO
Klin Monbl Augenheilkd; 1998 Dec; 213(6):331-40. PubMed ID: 10048010
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
18. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
19. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
20. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
